- Home
- RGNX vs WLKP Comparison
RGNX vs WLKP Comparison
Compare RGNX & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | WLKP |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.2M | 652.0M |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RGNX | WLKP |
|---|---|---|
| Price | $14.24 | $19.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $30.29 | N/A |
| AVG Volume (30 Days) | ★ 626.9K | 64.9K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 9.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.39 |
| Revenue | $161,318,000.00 | ★ $1,133,706,000.00 |
| Revenue This Year | $132.80 | $3.88 |
| Revenue Next Year | $48.47 | $12.71 |
| P/E Ratio | ★ N/A | $14.17 |
| Revenue Growth | ★ 91.30 | N/A |
| 52 Week Low | $5.04 | $17.75 |
| 52 Week High | $14.24 | $25.04 |
Technical Indicators
Market Signals| Indicator | RGNX | WLKP |
|---|---|---|
| Relative Strength Index (RSI) | 65.99 | 53.39 |
| Support Level | $12.69 | $18.88 |
| Resistance Level | $13.42 | $20.00 |
| Average True Range (ATR) | 0.84 | 0.40 |
| MACD | 0.12 | 0.14 |
| Stochastic Oscillator | 76.90 | 58.62 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About WLKP Westlake Chemical Partners LP
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.